• Consider Bloom Energy (BE) as a way to gain exposure to rising data-center power demand, but verify its ability to build projects at scale amid construction and regulatory hurdles.
• Treat Kodiak Sciences (KOD) as a high-risk, crowded short rather than an actionable bearish trade: the speaker remains skeptical of its drug evidence, but acknowledged that potential $200–$600 million revenue and high short interest could drive further gains.
• Avoid trading Iovance (IOVA) solely on the mixed momentum comments; the stock was described as both likely to climb and overextended, with no price target or clear timeframe.

Kodiak Sciences (KOD)

• The speaker described a large loss from shorting KOD and said he had covered most of the position. He identified two mistakes: underestimating short interest and failing to account for how the market might respond to the story.
• His fundamental view remained bearish:
  • He argued that the company’s 501 drug did not appear to add meaningful benefit over its other drug.
  • He criticized the evidence for tercocumab, including results he characterized as slightly inferior on one measure.
  • He said the study was unblinded and uncontrolled, making comparisons difficult.
  • He questioned whether insurers would pay more for a drug he viewed as similar to existing options.
• He also acknowledged the opposing case: the ophthalmology drug market is large, and even a product he considers only modestly differentiated might generate meaningful revenue. He suggested revenue in the $200 million–$600 million range could support a substantially higher valuation.
• He said short interest, market enthusiasm for ophthalmology products, and the possibility of meaningful sales contributed to the stock’s sharp rise.

Takeaways

• The discussion illustrates how a strong fundamental short thesis can still lose money when short interest, market positioning, and potential revenue are underestimated.
• For a biotech short, compare the clinical evidence and likely reimbursement with the possibility that a “me-too” product can still win a niche and generate sales. The speaker did not withdraw his negative view, but acknowledged that his timing and assessment of the market opportunity were flawed.

Invivyd (IVVD)

• The speaker said IVVD looked cheap, but he was unsure whether he understood the company’s fundamentals.
• He described its business as heavily dependent on COVID-related demand:
  • If COVID returns, he said the stock could rise many times over.
  • If it does not, he expected the company to have limited revenue.
• He said he would want to speak with the CEO to better understand the company’s plan.

Takeaways

• The central question raised was whether IVVD can build a durable business beyond a possible resurgence in COVID. Investigate the company’s strategy and revenue sources rather than relying only on a low valuation or a potential outbreak scenario.

Iovance Biotherapeutics (IOVA)

• The speaker said IOVA was likely to keep climbing, but later called it overextended and said it could be a good short.
• These were trading observations, not a clear long-term view or a specific recommendation.

Takeaways

• The comments point to a tension between near-term momentum and the risk of an extended move. Treat the speaker’s remarks as a short-term trading discussion, not a fundamental assessment.

MongoDB (MDB)

• The speaker questioned whether buying more MongoDB was a good idea and said it could go lower.
• He also said the company might provide guidance or other news on its earnings call and suggested listening to it.
• Later, MDB was discussed as a trade, but the speaker and another participant disagreed about whose position and profit it represented.

Takeaways

• The transcript offers a cautious, mixed view, not a consistent investment thesis. Review the company’s own earnings and guidance before drawing conclusions from the trading commentary.

Bloom Energy (BE)

• The speaker was strongly positive about Bloom Energy’s stock performance, calling it “so strong.”
• He linked the opportunity to the expected growth in data centers and said Bloom has a fuel-cell solution.
• He also raised practical challenges: the system may be difficult to build and regulate. He mentioned small modular reactors as another possible approach, while noting that those were not yet fully deployed.

Takeaways

• The investment theme is rising power demand from data centers, with fuel cells and small modular reactors presented as possible solutions.
• The speaker’s enthusiasm was tempered by construction and regulatory challenges. Assess whether the company can deliver projects at scale, not just whether the demand theme is attractive.

Beyond Meat (BYND)

• The speaker said BYND could be a short and noted that he had traded it several times.
• He did not provide a detailed fundamental rationale in the transcript.

Takeaways

• The bearish comment was brief and unsupported by a company-specific analysis in this discussion. Treat it as a trading opinion rather than a developed short thesis.

AOI (as named in the transcript; ticker/company not established)

• The speaker called it a momentum stock and said it could serve as a barometer for speculative retail activity.
• He also called it a “decent short” and criticized its chart, while noting that it makes a commodity-like product that is currently in demand.

Takeaways

• The speaker described both momentum and short potential, making the outlook explicitly mixed. Verify the company identity and fundamentals before acting on the ticker reference.

Moderna (MRNA)

• The speaker said Moderna appeared to be in a downtrend and mentioned a possible “double top” pattern.
• No company-specific fundamental analysis or price target was provided.

Takeaways

• The bearish signal was based on chart interpretation. The speaker elsewhere expressed skepticism about technical patterns, so this should be viewed as a tentative trading observation rather than a firm recommendation.

Micron Technology (MU)

• The speaker said Micron’s upcoming earnings report would be “real interesting” and identified it as reporting the following evening.
• No earnings expectations or forecast were provided.

Takeaways

• The transcript highlights the earnings event as a potential catalyst but gives no directional view. Review the company’s results and guidance rather than assuming the report will be positive or negative.

NVIDIA (NVDA)

• NVIDIA was described as having sold off during the trading session, and the speaker mentioned holding it overnight.
• Another participant was said to be up on the stock, but no investment thesis, price target, or timeframe beyond the overnight position was given.

Takeaways

• The discussion reflects active trading, not a long-term valuation view. Do not interpret the reported position or short-term performance as a broader recommendation.

Advanced Micro Devices (AMD)

• AMD was mentioned in an opening anecdote about a portfolio manager asking why the portfolio did not own the stock; the story was not investment analysis.
• Later, AMD was listed among positions being held overnight, without a stated thesis.

Takeaways

• The transcript provides no substantive view on AMD’s prospects. The anecdote and mention of an overnight position are not enough to form an investment conclusion.

Sandisk (SNDK)

• A trader was described as being up “quite a lot” on Sandisk.
• No reason for the gain or view on the company’s future was provided.

Takeaways

• The mention reflects a reported trading gain, not a fundamental outlook. No actionable company-specific thesis was discussed.

Ultragenyx Pharmaceutical (RARE)

• The speaker said he was bullish on Ultragenyx and described it as an example of the types of stocks the group also likes.
• He did not explain the thesis or identify a catalyst.

Takeaways

• The sentiment was positive, but the transcript offers no supporting details. Further research is needed before treating this as a developed investment view.

OpenAI

• The speaker said a $1.4 trillion fundraise had become official. This figure is reported as stated in the transcript and was not independently explained there.
• He discussed the possibility of OpenAI going public and argued that a listing would not automatically force investors to sell other stocks to make room for it.
• He said a public listing could make shares more liquid and easier to trade, while noting that early investors might sell to cash out.
• The transcript also cited 1.2 billion weekly active ChatGPT users and described that as bullish.
• The speaker argued that adding public shares does not, by itself, mean aggregate market value must fall.

Takeaways

• The discussion highlights OpenAI’s scale and the potential market impact of a future listing, but it does not provide a confirmed IPO date or a direct way to invest.
• A listing could improve access and liquidity for shares, while investor selling and demand would still affect the price. The user figure and fundraising amount should be verified independently before relying on them.

Anthropic (referred to as “Tropic” in the transcript)

• The speaker mentioned the possibility of “whoever lists Tropic” in a discussion of AI companies going public.
• No timing, valuation, or investment recommendation was provided.

Takeaways

• The mention signals interest in potential public-market access to AI companies, but the transcript gives no concrete IPO information. Treat a possible listing as speculative.

AI, Data Centers, and Power Infrastructure

• The speaker connected expected data-center construction with rising demand for power and discussed Bloom Energy’s fuel cells as one possible solution.
• He also mentioned small modular reactors, while noting that they had not yet been fully outfitted and deployed.
• A proposed strong executive order on AI was mentioned, but the speaker said he did not know what it would mean for markets.

Takeaways

• The transcript identifies data-center power demand as an investment theme, but the outcome may depend on whether proposed technologies can be built, regulated, and deployed effectively.
• The AI policy comment was too vague to support a specific investment conclusion.

Other Stocks Mentioned

ASML Holding (ASML), SK Hynix, and Taiwan Semiconductor (TSMC)

• These semiconductor names came up in trading commentary. The speaker noted NVIDIA’s selloff and referred to trades in ASML and Hynix; a participant was said to have made money on Hynix.
• No company-specific outlook or longer-term thesis was given.

Takeaways

• The comments show active trading across semiconductor stocks but do not establish a sector-wide recommendation. The transcript gives no comparative analysis of the companies.

Applied Materials (AMAT)

• AMAT was mentioned alongside a press release, but the speaker did not explain its contents or the implications.

Takeaways

• No investment conclusion can be drawn from the brief reference. The press release and its relevance would need to be reviewed separately.

QTTB, Nektar Therapeutics (NKTR), SLS, and Regeneron (REGN)

• QTTB was described as a stock the speaker had heard people wanted to trade, but he said he did not know much about it.
• He likewise said he did not know enough about Nektar to trade it.
• SLS and Regeneron were mentioned without meaningful analysis.

Takeaways

• These were passing references, not endorsements or developed investment theses. The speaker explicitly said he lacked sufficient knowledge of some of them.

Cure-related stock (identity unclear)

• The speaker said that after the stock “got wrecked,” it might have been worth a small buy for a bounce, while also saying he would not want to “marry” the position because of concerns about the drug.
• The company and ticker are unclear in the transcript.

Takeaways

• This was framed as a possible short-term bounce trade, not a long-term investment view. The unclear identity and the speaker’s stated concerns make it unsuitable as a standalone investment signal.

Financial Modeling and Market Approach

• The speaker argued that a useful financial model depends on choosing the right business drivers, not on building a complicated spreadsheet.
• He said modeling requires judgment and industry insight, whereas some coding tasks may be more amenable to AI because they involve repetitive work.
• He also said he does not rely on technical-analysis labels such as support levels, though he pays attention to price action and volume.
• He emphasized knowing the companies one trades and understanding both fundamentals and market positioning.

Takeaways

• For company analysis, focus on the assumptions that drive revenue, margins, and cash flow rather than spreadsheet complexity.
• For trading decisions, the discussion supports combining company-specific research with awareness of price action, volume, short interest, and investor expectations—while recognizing that none of these guarantees an outcome.